Detalles de la búsqueda
1.
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Oncologist
; 25(7): e1070-e1076, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154636
2.
Five- to 10-Year Prospective Follow-Up of Wrist Arthroplasty in 56 Nonrheumatoid Patients.
J Hand Surg Am
; 42(10): 788-796, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844772
3.
Supercharging of the ulnar nerve: clinical and neurophysiological assessment at 2 years for nine proximal injuries.
J Hand Surg Eur Vol
; : 17531934231226174, 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235708
4.
Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects.
ESMO Open
; 5(4)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847837
5.
European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma.
ESMO Open
; 5(6): e000798, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188050
6.
European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis.
ESMO Open
; 4(6)2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392175
7.
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases.
Clin Genitourin Cancer
; 11(1): 20-6, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23021204
8.
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.
Lancet Oncol
; 8(7): 587-94, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17544845
Resultados
1 -
8
de 8
1
Próxima >
>>